Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

Escitalopram has been claimed to have the highest selectivity for the human serotonin transporter relative to the noradrenaline or dopamine transporters. This might be associated with greater clinical efficacy. Most adverse events reported by escitalopram-treated patients are mild and transient.

In this study, we compare escitalopram with placebo in the treatment of PE.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• One hundred married patients seek medical help for what they consider premature ejaculation with possible sexual intercourse equal or greater than 1 per week.

Exclusion Criteria:

• Erectile dysfunction accounting to Arabic version of IIEF(International Index of Erectile Dysfunction)

• Chronic psychiatric or physical illness.

• Alcohol or substance abuse.

• Use of psychotropic and antidepressant medication.

• Patient with prostatitis

• Organic illness causing limitation of SSRI use.